<html lang="en">
<head>
<meta charset="utf-8"/>
<title offset="1245">Cystathionine beta synthase</title>
<script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_SVG.js" type="text/javascript">
</script>
</head>
<body>
<h1>Cystathionine beta synthase</h1>
<hr/>

<p><strong>Cystathionine-β-synthase</strong>, also known as <strong>CBS</strong>, is an <a class="uri" href="enzyme" title="wikilink">enzyme</a> () that in humans is encoded by the <em>CBS</em> <a class="uri" href="gene" title="wikilink">gene</a>. It catalyzes the first step of the <a class="uri" href="transsulfuration" title="wikilink">transsulfuration</a> pathway, from <a class="uri" href="homocysteine" title="wikilink">homocysteine</a> to <a class="uri" href="cystathionine" title="wikilink">cystathionine</a>:<a class="footnoteRef" href="#fn1" id="fnref1"><sup>1</sup></a></p>
<dl>
<dd><a href="Serine" title="wikilink">L-serine</a> + <a href="homocysteine" title="wikilink">L-homocysteine</a> 

<math display="inline" id="Cystathionine_beta_synthase:0">
 <semantics>
  <mo>⇌</mo>
  <annotation-xml encoding="MathML-Content">
   <ci>normal-⇌</ci>
  </annotation-xml>
  <annotation encoding="application/x-tex">
   \rightleftharpoons
  </annotation>
 </semantics>
</math>

 <a href="cystathionine" title="wikilink">L-cystathionine</a> + <a href="water_(molecule)" title="wikilink">H<sub>2</sub>O</a>
</dd>
</dl>

<p>CBS uses the <a href="Cofactor_(biochemistry)" title="wikilink">cofactor</a> <a class="uri" href="pyridoxal-phosphate" title="wikilink">pyridoxal-phosphate</a> (PLP) and can be <a class="uri" href="allosterically" title="wikilink">allosterically</a> regulated by effectors such as the ubiquitous cofactor <a class="uri" href="S-adenosyl-L-methionine" title="wikilink">S-adenosyl-L-methionine</a> (adoMet). This enzyme belongs to the family of <a href="lyase" title="wikilink">lyases</a>, to be specific, the hydro-lyases, which cleave carbon-oxygen bonds.</p>

<p>CBS is a multidomain enzyme composed of an N-terminal enzymatic domain and two <a href="CBS_domain" title="wikilink">CBS domains</a>. The <em>CBS</em> gene is the most common locus for mutations associated with <a class="uri" href="homocystinuria" title="wikilink">homocystinuria</a>.<a class="footnoteRef" href="#fn2" id="fnref2"><sup>2</sup></a></p>
<h2 id="nomenclature">Nomenclature</h2>

<p>The systematic name of this enzyme class is L-serine hydro-lyase (adding homocysteine; L-cystathionine-forming). Other names in common use include:</p>
<ul>
<li>beta-thionase,</li>
<li>cysteine synthase,</li>
<li>L-serine hydro-lyase (adding homocysteine),</li>
<li>methylcysteine synthase,</li>
<li>serine sulfhydrase, and</li>
<li>serine sulfhydrylase.</li>
</ul>

<p><strong>Methylcysteine synthase</strong> was assigned the <a href="Enzyme_Commission_number" title="wikilink">EC number</a> EC 4.2.1.23 in 1961. A side-reaction of CBS caused this. The EC number EC 4.2.1.23 was deleted in 1972. <a class="footnoteRef" href="#fn3" id="fnref3"><sup>3</sup></a></p>
<h2 id="structure">Structure</h2>

<p> The human enzyme cystathionine β-synthase is a <a href="tetrameric_protein" title="wikilink">tetramer</a> and comprises 551 <a href="amino_acid" title="wikilink">amino acids</a> with a subunit molecular weight of 63 kDa. It displays a modular organization of three modules with the N-terminal heme domain followed by a core that contains the <a href="pyridoxal-phosphate" title="wikilink">PLP</a> cofactor.<a class="footnoteRef" href="#fn4" id="fnref4"><sup>4</sup></a> The cofactor is deep in the heme domain and is linked by a Schiff base.<a class="footnoteRef" href="#fn5" id="fnref5"><sup>5</sup></a> A <a href="Schiff_base" title="wikilink">Schiff base</a> is a <a href="functional_group" title="wikilink">functional group</a> containing a C=N bond with the nitrogen atom connected to an <a class="uri" href="aryl" title="wikilink">aryl</a> or <a class="uri" href="alkyl" title="wikilink">alkyl</a> group. The heme domain is composed of 70 amino acids and it appears that the heme only exists in <a href="mammal" title="wikilink">mammalian</a> CBS and is absent in yeast and <a class="uri" href="protozoan" title="wikilink">protozoan</a> CBS. At the C-terminus, the regulatory domain of CBS contains a tandem repeat of two CBS domains of β-α-β-β-α, a secondary structure motif found in other proteins.<a class="footnoteRef" href="#fn6" id="fnref6"><sup>6</sup></a> CBS has a C-terminal inhibitory domain. The C-terminal domain of cystathionine β-synthase regulates its activity via both intrasteric and allosteric effects and is important for maintaining the tetrameric state of the protein.<a class="footnoteRef" href="#fn7" id="fnref7"><sup>7</sup></a> This inhibition is alleviated by binding of the <a class="uri" href="allosteric" title="wikilink">allosteric</a> effector, <a href="S-Adenosyl_methionine" title="wikilink">adoMet</a>, or by deletion of the regulatory domain; however, the magnitude of the effects differ.<a class="footnoteRef" href="#fn8" id="fnref8"><sup>8</sup></a> Mutations in this domain are correlated with <a href="hereditary_disease" title="wikilink">hereditary diseases</a>.<a class="footnoteRef" href="#fn9" id="fnref9"><sup>9</sup></a></p>

<p>The heme domain contains an N-terminal loop that binds heme and provides the axial <a href="ligand" title="wikilink">ligands</a> C52 and H65. The distance of heme from the <a href="pyridoxal-phosphate" title="wikilink">PLP</a> binding site suggests its non-role in catalysis, however deletion of the heme domain causes loss of <a class="uri" href="redox" title="wikilink">redox</a> sensitivity, therefore it is hypothesized that heme is a redox sensor.<a class="footnoteRef" href="#fn10" id="fnref10"><sup>10</sup></a> The presence of protoporphyrin IX in CBS is a unique PLP-dependent enzyme and is only found in the mammalian CBS. <a href="Drosophila_melanogaster" title="wikilink"><em>D. melanogaster</em></a> and <a href="Dictyostelium_discoides" title="wikilink"><em>D. discoides</em></a> have truncated <a href="N-terminus" title="wikilink">N-terminal</a> extensions and therefore prevent the conserved <a class="uri" href="histidine" title="wikilink">histidine</a> and <a class="uri" href="cysteine" title="wikilink">cysteine</a> heme ligand <a href="residue_(chemistry)" title="wikilink">residues</a>. However, the <em><a href="Anopheles_gambiae" title="wikilink">Anopheles gambiae</a></em> sequence has a longer N-terminal extension than the human enzyme and contains the conserved <a class="uri" href="histidine" title="wikilink">histidine</a> and <a class="uri" href="cysteine" title="wikilink">cysteine</a> <a class="uri" href="heme" title="wikilink">heme</a> ligand residues like the human <a class="uri" href="heme" title="wikilink">heme</a>. Therefore, it is possible that CBS in slime molds and insects are hemeproteins that suggest that the <a class="uri" href="heme" title="wikilink">heme</a> domain is an early evolutionary innovation that arose before the separation of animals and the slime molds.<a class="footnoteRef" href="#fn11" id="fnref11"><sup>11</sup></a> The <a href="pyridoxal-phosphate" title="wikilink">PLP</a> is an internal <a class="uri" href="aldimine" title="wikilink">aldimine</a> and forms a <a href="Schiff_base" title="wikilink">Schiff base</a> with K119 in the active site. Between the catalytic and regulatory domains exists a hypersensitive site that causes proteolytic cleavage and produces a truncated <a href="protein_dimer" title="wikilink">dimeric</a> enzyme that is more active than the original enzyme. Both truncated enzyme and the enzyme found in yeast are not regulated by adoMet. The yeast enzyme is also activated by the deletion of the C-terminal to produce the dimeric enzyme.<a class="footnoteRef" href="#fn12" id="fnref12"><sup>12</sup></a></p>

<p>As of late 2007, two <a href="tertiary_structure" title="wikilink">structures</a> have been solved for this class of enzymes, with <a href="Protein_Data_Bank" title="wikilink">PDB</a> accession codes  and .</p>

<p>{{-}}</p>
<h2 id="enzymatic-activity">Enzymatic activity</h2>
<figure><b>(Figure)</b>
<figcaption>Cysteine metabolism. Cystathionine beta synthase catalyzes the upper reaction and <a href="cystathionine_gamma-lyase" title="wikilink">cystathionine gamma-lyase</a> catalyzes the lower reaction.</figcaption>
</figure>

<p>Transsulfuration, catalyzed by CBS, converts <a class="uri" href="homocysteine" title="wikilink">homocysteine</a> to <a class="uri" href="cystathionine" title="wikilink">cystathionine</a>, which cystathione gamma lyase converts to <a class="uri" href="cysteine" title="wikilink">cysteine</a>.<a class="footnoteRef" href="#fn13" id="fnref13"><sup>13</sup></a></p>

<p>CBS occupies a pivotal position in mammalian sulfur metabolism at the <a class="uri" href="homocysteine" title="wikilink">homocysteine</a> junction where the decision to conserve <a class="uri" href="methionine" title="wikilink">methionine</a> or to convert it to cysteine via the <a href="transsulfuration_pathway" title="wikilink">transsulfuration pathway</a>, is made. Moreover, the transsulfuration pathway is the only pathway capable of removing sulfur-containing <a href="amino_acids" title="wikilink">amino acids</a> under conditions of excess.<a class="footnoteRef" href="#fn14" id="fnref14"><sup>14</sup></a></p>

<p>In analogy with other β-replacement enzymes, the reaction catalyzed by CBS is predicted to involve a series of <a href="S-adenosyl-L-methionine" title="wikilink">adoMet</a>-bound intermediates. Addition of <a class="uri" href="serine" title="wikilink">serine</a> results in a <a href="Schiff_base" title="wikilink">transchiffization</a> reaction, which forms of an external <a class="uri" href="aldimine" title="wikilink">aldimine</a>. The <a class="uri" href="aldimine" title="wikilink">aldimine</a> undergoes proton abstraction at the α-carbon followed by elimination to generate an amino-<a class="uri" href="acrylate" title="wikilink">acrylate</a> intermediate. Nucleophilic attack by the thiolate of homocysteine on the aminoacrylate and reprotonation at Cα generate the external aldimine of <a class="uri" href="cystathionine" title="wikilink">cystathionine</a>. A final <a class="uri" href="transaldimination" title="wikilink">transaldimination</a> reaction releases the final product, cystathionine.<a class="footnoteRef" href="#fn15" id="fnref15"><sup>15</sup></a> The final product, L-cystathionine can also form an aminoacrylate intermediate, indicating that the entire reaction of CBS is reversible.<a class="footnoteRef" href="#fn16" id="fnref16"><sup>16</sup></a></p>

<p>The measured V<sub>0</sub> of an enzyme-catalyzed reaction, in general, reflects the steady state (where [ES] is constant), even though V<sub>0</sub> is limited to the early part of a reaction, and analysis of these initial rates is referred to as steady-state kinetics. Steady-state kinetic analysis of yeast CBS yields parallel lines. These results agree with the proposed ping-pong mechanism in which serine binding and release of water are followed by homocysteine binding and release of cystathionine. In contrast, the steady-state <a href="enzyme_kinetics" title="wikilink">enzyme kinetics</a> of rat CBS yields intersecting lines, indicating that the β-substitutent of serine is not released from the enzyme prior to binding of homocysteine.<a class="footnoteRef" href="#fn17" id="fnref17"><sup>17</sup></a></p>

<p>One of the alternate reactions involving CBS is the condensation of <a class="uri" href="cysteine" title="wikilink">cysteine</a> with homocysteine to form cystathionine and <a href="hydrogen_sulfide" title="wikilink">hydrogen sulfide</a> (H<sub>2</sub>S).<a class="footnoteRef" href="#fn18" id="fnref18"><sup>18</sup></a> H<sub>2</sub>S in the brain is produced from L-cysteine by CBS. This alternative metabolic pathway is also dependent on <a href="S-adenosyl-L-methionine" title="wikilink">adoMet</a>.<a class="footnoteRef" href="#fn19" id="fnref19"><sup>19</sup></a></p>

<p>CBS enzyme activity is not found in all tissues and cells. It is absent from heart, lung, testes, adrenal, and spleen in rats. In humans, it has been shown to be absent in heart muscle and primary cultures of human aortic <a class="uri" href="endothelial" title="wikilink">endothelial</a> cells. The lack of CBS in these tissues implies that these tissues are unable to synthesize cysteine and that cysteine must be supplied from extracellular sources. It also suggests that these tissues might have increased sensitivity to homocysteine toxicity because they cannot catabolize excess homocysteine via transsulfuration.<a class="footnoteRef" href="#fn20" id="fnref20"><sup>20</sup></a></p>
<h2 id="regulation">Regulation</h2>

<p><a href="allosteric_regulation" title="wikilink">Allosteric activation</a> of CBS by <a href="S-adenosyl-L-methionine" title="wikilink">adoMet</a> determines the metabolic fate of <a class="uri" href="homocysteine" title="wikilink">homocysteine</a>. Mammalian CBS is activated 2.5-5-fold by AdoMet with a <a href="dissociation_constant" title="wikilink">dissociation constant</a> of 15 µM.<a class="footnoteRef" href="#fn21" id="fnref21"><sup>21</sup></a> <a href="S-adenosyl-L-methionine" title="wikilink">AdoMet</a> is an allosteric activator that increases the <a href="Michaelis–Menten_kinetics" title="wikilink">V<sub>max</sub></a> of the CBS reaction but does not affect the <a href="Michaelis–Menten_kinetics" title="wikilink">K<sub>m</sub></a> for the substrates. In other words, AdoMet stimulates CBS activity by increasing the turnover rate rather than the binding of substrates to the enzyme.<a class="footnoteRef" href="#fn22" id="fnref22"><sup>22</sup></a> This protein may use the <a class="uri" href="morpheein" title="wikilink">morpheein</a> model of <a href="allosteric_regulation" title="wikilink">allosteric regulation</a>. <a class="footnoteRef" href="#fn23" id="fnref23"><sup>23</sup></a></p>

<p>Human CBS performs a crucial step in the <a href="Cysteine#Biosynthesis" title="wikilink">biosynthetic pathway of cysteine</a> by providing a regulatory control point for AdoMet. Homocysteine, after being methylated to <a class="uri" href="methionine" title="wikilink">methionine</a>, can be converted to AdoMet, which donates <a class="uri" href="methyl" title="wikilink">methyl</a> groups to a variety of substrates, e.g., <a class="uri" href="neurotransmitters" title="wikilink">neurotransmitters</a>, <a class="uri" href="proteins" title="wikilink">proteins</a>, and <a href="nucleic_acids" title="wikilink">nucleic acids</a>. AdoMet functions as an allosteric activator of CBS and exerts control on its biosynthesis: low concentrations of AdoMet result in low CBS activity, thereby funneling homocysteine into the <a href="transmethylation" title="wikilink">transmethylation cycle</a> toward AdoMet formation. In contrast, high adoMet concentrations funnel homocysteine into the <a href="transsulfuration_pathway" title="wikilink">transsulfuration pathway</a> toward <a href="Cysteine#Biosynthesis" title="wikilink">cysteine biosynthesis</a>.<a class="footnoteRef" href="#fn24" id="fnref24"><sup>24</sup></a></p>

<p>In mammals, CBS is a highly regulated enzyme, which contains a <a class="uri" href="heme" title="wikilink">heme</a> cofactor that functions as a redox sensor,<a class="footnoteRef" href="#fn25" id="fnref25"><sup>25</sup></a> that can modulate its activity in response to changes in the redox potential. If the resting form of CBS in the cell has <a class="uri" href="ferrous" title="wikilink">ferrous</a> (Fe<sup>2+</sup>) heme, the potential exists for activating the enzyme under oxidizing conditions by conversion to the <a class="uri" href="ferric" title="wikilink">ferric</a> (Fe<sup>3+</sup>) state.<a class="footnoteRef" href="#fn26" id="fnref26"><sup>26</sup></a> The Fe<sup>2+</sup> form of the enzyme is inhibited upon binding CO or nitric oxide, whereas enzyme activity is doubled when the Fe<sup>2+</sup> is oxidized to Fe<sup>3+</sup>. The redox state of the <a class="uri" href="heme" title="wikilink">heme</a> is pH dependent, with oxidation of Fe<sup>2+</sup>–CBS to Fe<sup>3+</sup>–CBS being favored at low pH conditions.<a class="footnoteRef" href="#fn27" id="fnref27"><sup>27</sup></a></p>

<p>Since mammalian CBS contains a heme cofactor, whereas yeast and protozoan enzyme from Trypanosoma cruzi do not have heme cofactors, researchers have speculated that heme is not required for CBS activity.<a class="footnoteRef" href="#fn28" id="fnref28"><sup>28</sup></a></p>

<p>CBS is regulated at the transcriptional level by <a href="NFYA" title="wikilink">NF-Y</a>, <a href="Sp1_transcription_factor" title="wikilink">SP-1</a>, and <a href="Sp3_transcription_factor" title="wikilink">SP-3</a>. In addition it is upregulated transcriptionally by <a href="glucocorticoid" title="wikilink">glucocorticoids</a> and <a class="uri" href="glycogen" title="wikilink">glycogen</a>, and downregulated by <a class="uri" href="insulin" title="wikilink">insulin</a>. Methionine upregulates CBS at the post-transcriptional level.</p>
<h2 id="human-disease">Human disease</h2>

<p><a href="Down_syndrome" title="wikilink">Down syndrome</a> is a medical condition characterized by an overexpression of cystathionine beta synthase (CBS) and a low level of homocysteine in the blood. It has been speculated that cystathionine beta synthase overexpression could be the major culprit in this disease (along with dysfunctioning of GabaA and Dyrk1a). The phenotype of down syndrome is the opposite of Hyperhomocysteinemia (described below). Pharmacologicals inhibitors of CBS have been patented by the Jerome Lejeune Foundation (November 2011) and trials (animals and humans are planned).</p>

<p><a class="uri" href="Hyperhomocysteinemia" title="wikilink">Hyperhomocysteinemia</a> is a medical condition characterized by an abnormally large level of <a class="uri" href="homocysteine" title="wikilink">homocysteine</a> in the blood. Mutations in CBS are the single most common cause of hereditary hyperhomocysteinemia. Inborn errors in CBS result in <a class="uri" href="hyperhomocysteinemia" title="wikilink">hyperhomocysteinemia</a> with complications in the cardiovascular system leading to early and aggressive arterial disease. <a class="uri" href="Hyperhomocysteinemia" title="wikilink">Hyperhomocysteinemia</a> also affects three other major organ systems including the ocular, central nervous, and skeletal.<a class="footnoteRef" href="#fn29" id="fnref29"><sup>29</sup></a></p>

<p><a class="uri" href="Homocystinuria" title="wikilink">Homocystinuria</a> due to CBS deficiency is a special type of hyperhomocysteinemia. It is a rare, hereditary recessive autosomal disease, in general, diagnosed during childhood. A total of 131 different homocystinuria-causing mutations have been identified. A common functional feature of the mutations in the CBS domains is that the mutations abolish or strongly reduce activation by <a href="S-adenosyl-L-methionine" title="wikilink">adoMet</a>.<a class="footnoteRef" href="#fn30" id="fnref30"><sup>30</sup></a> No specific cure has been discovered for homocystinuria; however, many people are treated using high doses of <a href="vitamin_B6" title="wikilink">vitamin B<sub>6</sub></a>, which is a cofactor of CBS.</p>
<h2 id="bioengineering">Bioengineering</h2>

<p>Cystathionine beta synthase (CBS) is involved in <a class="uri" href="oocyte" title="wikilink">oocyte</a> development. However, little is known about the regional and cellular expression patterns of CBS in the ovary and research is now focused on determining the location and expression during follicle development in the ovaries.<a class="footnoteRef" href="#fn31" id="fnref31"><sup>31</sup></a></p>
<h2 id="see-also">See also</h2>
<ul>
<li><a class="uri" href="Homocystinuria" title="wikilink">Homocystinuria</a></li>
<li><a class="uri" href="Cysteine" title="wikilink">Cysteine</a></li>
<li><a class="uri" href="Metabolism" title="wikilink">Metabolism</a></li>
<li><a href="Amino_Acids" title="wikilink">Amino Acids</a></li>
<li><a class="uri" href="S-Adenosyl-L-methionine" title="wikilink">S-Adenosyl-L-methionine</a></li>
<li><a class="uri" href="Heme" title="wikilink">Heme</a></li>
</ul>
<h2 id="references">References</h2>
<h2 id="further-reading">Further reading</h2>
<h2 id="external-links">External links</h2>
<ul>
<li><a href="http://www.uchsc.edu/cbs/cbsdata/cbs_02.htm">CBS Main Page at University of Colorado Health Sciences Center</a></li>
<li><a href="http://www.brenda.uni-koeln.de/index.php4?page=information/all_enzymes.php4?ecno=4.2.1.22">Cystathionine beta-synthase in BRENDA: The Comprehensive Enzyme Information System</a></li>
<li><a href="http://www.rcsb.org/pdb/explore.do?structureId=1JBQ">Cystathionine beta-Synthase: Protein Data Bank Entry</a></li>
</ul>

<p>"</p>

<p><a href="Category:EC_4.2.1" title="wikilink">Category:EC 4.2.1</a> <a href="Category:Pyridoxal_phosphate_enzymes" title="wikilink">Category:Pyridoxal phosphate enzymes</a> <a href="Category:Enzymes_of_known_structure" title="wikilink">Category:Enzymes of known structure</a></p>
<section class="footnotes">
<hr/>
<ol>
<li id="fn1"><a href="#fnref1">↩</a></li>
<li id="fn2"><a href="#fnref2">↩</a></li>
<li id="fn3"><a href="http://www.chem.qmul.ac.uk/iubmb/enzyme/EC4/2/1/23.html">EC 4.2.1.23</a><a href="#fnref3">↩</a></li>
<li id="fn4"><a href="#fnref4">↩</a></li>
<li id="fn5"><a href="#fnref5">↩</a></li>
<li id="fn6"></li>
<li id="fn7"></li>
<li id="fn8"></li>
<li id="fn9"><a href="#fnref9">↩</a></li>
<li id="fn10"></li>
<li id="fn11"></li>
<li id="fn12"></li>
<li id="fn13"><a href="#fnref13">↩</a></li>
<li id="fn14"></li>
<li id="fn15"></li>
<li id="fn16"><a href="#fnref16">↩</a></li>
<li id="fn17"></li>
<li id="fn18"></li>
<li id="fn19"><a href="#fnref19">↩</a></li>
<li id="fn20"></li>
<li id="fn21"></li>
<li id="fn22"></li>
<li id="fn23"><a href="#fnref23">↩</a></li>
<li id="fn24"><a href="#fnref24">↩</a></li>
<li id="fn25"></li>
<li id="fn26"></li>
<li id="fn27"><a href="#fnref27">↩</a></li>
<li id="fn28"></li>
<li id="fn29"></li>
<li id="fn30"></li>
<li id="fn31"><a href="#fnref31">↩</a></li>
</ol>
</section>
</body>
</html>
